| Jeffrey Trigilio |
jtr******@cullinanoncology.com
|
cullinanoncology.com |
Chief Financial Officer |
|
New York, NY, US |
|
| Karsten Sauer |
ksa***@cullinanoncology.com
|
cullinanoncology.com |
Vice President, Preclinical R and D |
|
Cambridge, MA, US |
|
| Jennifer Michaelson |
jmi********@cullinanoncology.com
|
cullinanoncology.com |
Chief Scientific Officer |
|
Boston, Massachusetts, United States |
|
| Sal Firicano |
sfi******@cullinanoncology.com
|
cullinanoncology.com |
VP and Head of Information Technology |
|
Melrose, MA, US |
|
| Phill Gallacher |
pga*******@cullinanoncology.com
|
cullinanoncology.com |
VP, Clinical Development Operations and Clinical Program Management |
|
Boston, MA, US |
|
| Mark Melville |
mme******@cullinanoncology.com
|
cullinanoncology.com |
Vice President of Cmc, Biologics |
|
Melrose, MA, US |
|
| Jeffrey Jones |
jjo***@cullinanoncology.com
|
cullinanoncology.com |
|
|
New York, NY, US |
|
| Chad Messer |
cme****@cullinanoncology.com
|
cullinanoncology.com |
Vice President of Investor Relations |
|
New York, NY, US |
|
| Brian Stuglik |
bst*****@verastem.com
|
verastem.com |
Chief Executive Officer |
|
United States |
|
| Jonathan Pachter |
jpa*****@verastem.com
|
verastem.com |
Chief Scientific Officer |
|
Boston, MA, US |
|